SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006094
Filing Date
2024-02-13
Accepted
2024-02-13 16:27:01
Documents
18
Period of Report
2024-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52522
2 ex1-1.htm EX-1.1 490530
3 ex4-1.htm EX-4.1 112217
4 ex99-1.htm EX-99.1 14200
5 ex99-2.htm EX-99.2 13114
  Complete submission text file 0001493152-24-006094.txt   991795

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE telo-20240208.xsd EX-101.SCH 3030
7 XBRL LABEL FILE telo-20240208_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE telo-20240208_pre.xml EX-101.PRE 22799
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3904
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

IRS No.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41952 | Film No.: 24626444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)